Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.44B | $4.45B | $4.66B | $6.38B | $7.06B | $7.39B | $7.70B | $7.44B | $7.48B | $7.26B |
| Revenue growth | — | 0.3% | 4.6% | 36.9% | 10.6% | 4.8% | 4.2% | -3.4% | 0.5% | -2.9% |
| Operating income | $263M | $256M | $220M | $370M | $390M | $462M | $501M | $741M | $563M | $521M |
| Operating margin | 5.9% | 5.7% | 4.7% | 5.8% | 5.5% | 6.2% | 6.5% | 10.0% | 7.5% | 7.2% |
| Net income | $143M | $179M | $137M | $229M | $211M | $279M | $303M | $477M | $362M | $358M |
| Net margin | 3.2% | 4.0% | 2.9% | 3.6% | 3.0% | 3.8% | 3.9% | 6.4% | 4.8% | 4.9% |
| EPS (diluted) | $3.12 | $4.02 | $3.11 | $3.83 | $3.56 | $4.77 | $5.38 | $8.88 | $7.17 | $7.70 |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $273M | $217M | $184M | $458M | $755M | $518M | $532M | $396M | $494M | $609M |
| Capital expenditures | $15.0M | $22.0M | $28.0M | $21.0M | $46.0M | $36.0M | $25.0M | $27.0M | $36.0M | $32.0M |
| Free cash flow | $258M | $195M | $156M | $437M | $709M | $482M | $507M | $369M | $458M | $577M |
| Share buybacks | $180M | $186M | $69.0M | $197M | $34.0M | $226M | $267M | $382M | $558M | $445M |
| Dividends paid | $54.0M | $54.0M | $53.0M | $87.0M | $87.0M | $86.0M | $83.0M | $79.0M | $75.0M | $70.0M |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $210M | $144M | $237M | $188M | $171M | $106M | $109M | $94.0M | $56.0M | $182M |
| Total assets | $2.04B | $2.07B | $4.56B | $4.71B | $5.72B | $5.75B | $5.54B | $5.31B | $5.25B | $5.35B |
| Long-term debt | $1.02B | $983M | $2.06B | $1.85B | $2.45B | $2.37B | $2.34B | $2.02B | $1.91B | $2.47B |
| Shareholders' equity | $349M | $327M | $1.49B | $1.42B | $1.54B | $1.62B | $1.69B | $1.78B | $1.58B | $1.50B |
| Retained earnings | $260M | $323M | $367M | $506M | $627M | $818M | $1.03B | $1.43B | $1.56B | $1.49B |
| Shares (wtd avg diluted) | 45.9M | 44.5M | 44.1M | 59.0M | 58.7M | 58.1M | 55.8M | 53.7M | 50.5M | 46.5M |
Every figure is extracted from Science Applications International Corp’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.